Neose Technologies Inc

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 25 pages Assignment of Non-Compete
12/34/56
EX-10.1
from 8-K 25 pages Assignment of Non-Compete
12/34/56
EX-10.1
from 8-K 93 pages Amendment to Registration Rights Agreement
12/34/56
EX-10.1
from DEFA14A 93 pages Amendment to Registration Rights Agreement
12/34/56
EX-10.3
from 10-Q 4 pages Neose Technologies, Inc. 2004 Equity Incentive Plan Non-Qualified Stock Option Award Agreement
12/34/56
EX-10.2
from 10-Q 16 pages Change of Control Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Schedule of Policies Covered by This Agreement
12/34/56
EX-10.33
from 10-K 49 pages Portions of This Exhibit Were Omitted and Filed Separately With the Secretary of the Commission Pursuant to an Application for Confidential Treatment Filed With the Commission Pursuant to Rule 24b-2 Under the Securities Exchange Act of 1934. Such Portions Are Marked by a Series of Asterisks. Research, Development and License Agreement Between Neose Technologies, Inc. and Novo Nordisk a/S Dated as of November 2, 2007
12/34/56
EX-10.32
from 10-K 49 pages Portions of This Exhibit Were Omitted and Filed Separately With the Secretary of the Commission Pursuant to an Application for Confidential Treatment Filed With the Commission Pursuant to Rule 24b-2 Under the Securities Exchange Act of 1934. Such Portions Are Marked by a Series of Asterisks. Research, Development and License Agreement Between Neose Technologies, Inc. and Novo Nordisk a/S Dated as of November 2, 2007
12/34/56
EX-10.8
from 10-Q 15 pages Change of Control Agreement
12/34/56
EX-10.7
from 10-Q 17 pages Change of Control Agreement
12/34/56
EX-10.6
from 10-Q 20 pages Amended and Restated Employment Agreement
12/34/56
EX-10.44
from 10-K 4 pages Schedule of Policies
12/34/56
EX-10.43
from 10-K 45 pages Bioprocessing Services Agreement
12/34/56
EX-10.42
from 10-K 56 pages Amended and Restated Research, Development and License Agreement Among Neose Technologies, Inc. and Novo Nordisk a/S and Novo Nordisk Health Care AG Dated as of October 31, 2006
12/34/56
EX-10.41
from 10-K 7 pages Amendment Number 1 to Research, Co-Development and Commercialization Agreement and Research License and Option Agreement
12/34/56
EX-10.4
from 8-K ~10 pages Material contract
12/34/56
EX-10.3
from 8-K ~10 pages Common Stock Purchase Warrant Neose Technologies, Inc
12/34/56
EX-10.2
from 8-K ~20 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K ~50 pages Securities Purchase Agreement
12/34/56